Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Heidi Taipale

Heidi Taipale

Lead researcher, University of Eastern Finland and Karolinska Institutet

Appears in 1 story

Stories

GLP-1 weight-loss drugs show unexpected psychiatric benefits in largest study to date

New Capabilities

Active researcher

Drugs originally designed to control blood sugar and reduce weight may also protect the brain. A study of 95,490 people in Sweden, published in The Lancet Psychiatry on March 22, 2026, found that semaglutide (the compound in Ozempic and Wegovy) reduced psychiatric hospitalizations, worsening depression, and substance-use crises.

Updated May 30